Intralesional Bleomycin Injections for the Palliation of Epistaxis in Hereditary Hemorrhagic Telangiectasia

References

1. ↵
   Begbie ME, Wallace GM, Shovlin CL. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21^st century. Postgrad Med J 2003;79:18–24

   Abstract/FREE Full Text
2. ↵
   Pau H, Carney AS, Murty GE. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): Otorhinolaryngological manifestations. Clin Otolaryngol 2001;26:39–98

   CrossRefPubMedWeb of Science
3. ↵
   Ishibashi T, Takamatsu S. Hereditary hemorrhagic telangiectasis treated by the harmonic scalpel. Head Neck 2003;25:333–336

   PubMed
4. ↵
   Farnan TB, Gallagher G, Scally CM. A novel treatment for patients with hereditary hemorrhagic telangiectasia. J Laryngol Otol 2002;116:849–850

   PubMed
5. ↵
   Cirulli A, Liso A, D’Ovido F, et al. Vascular Endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Hematol 2003;110:29–32
6. ↵
   Muir T, Kirstin M, Fourie P, Dippenaar N, Ionesco GO. Intralesional bleomycin injection (IBI) for hemangiomas and congenital vascular malformations. Paeditr Surg Int 2004;19:766–773
7. Fourie PA, Ionesco GO, Muir T, Coetzee PF. Results of 95 patients with hemangiomas and vascular malformations treated with intralesional Bleomycin (Suppl). Cardiovasc Interv Radiol 2002;25:S163
8. Kullendorff CM. Efficacy of bleomycin treatment for symptomatic hemangiomas in children. Pediatr Surg Int 1997;12:526–528

   PubMedWeb of Science
9. Wang C, Gao Q, Fu F, Wen Y, Dai X, Gang H, Lu X. Treatment of hemangioma in oral maxillofacial region with pingyangmycin injection (abstract [in Chinese]). Hua Xi Kou Qiang Yi Xue Za Zhi 2000;18:317–319

   PubMed
10. ↵
    Sanlialp I, Kamak I, Tanyel FC. Senocak ME, Büyükpamukçu N. Sclerotherapy for lymphangioma in children. Int J Pediatric Otorhinolaryngol 2003;67:795–800
11. ↵
    Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plastic Reconstr Surg 1982;69:412–420

    PubMedWeb of Science
12. ↵
    Bennett JM, Reich SD. Bleomycin. Ann Intern Med 1979;90:945–948
13. ↵
    Oikawa T, Hirotani K, Ogasawara H, et al. Inhibition of angiogenesis by bleomycin and its copper complex. Chem Pharm Bull (Tokyo) 1990;38:1790–1792

    PubMed
14. ↵
    Licun W, Gongjia S. Treatment of hemangioma with an angiogenesis inhibitor pingyangmycin. Indian Pediatr 2000;37:636–639

    PubMed
15. ↵
    Gao Q, Wang C, Wen Y, Li L, Zhang J, HE Z, Yang Z. An experimental study on effects of pingyangmycin on vessels (abstract [in Chinese]). Hua Xi Kou Qiang Yi Xue Za Zhi 2001;19:181–187

    PubMed
16. ↵
    Das UN. A radical approach to cancer. Med Sci Monit 2002;8:RA79–92

    PubMed